A complex of Rgnef, FAK, and paxillin promote colon carcinoma tumor cell motility and matrix degradation in vitro with corresponding increases in tumor growth and surrounding tissue invasion in vivo [25]. Here, ARHGEF28 is linked to colon carcinoma.